Coronavirus city Manchester hospital covid-19 NHS patient Coronavirus city Manchester

Manchester doctors are leading the way with drug that 'reduces number of deaths among COVID-19 patients'

Manchester University NHS Foundation Trust (MFT) hospitals, including the Manchester Royal Infirmary(MRI), Wythenshawe Hospital and North Manchester General.

Dr Felton said: "Dexamethasone, which is a type of steroid used in a range of conditions – typically to reduce inflammation – is the first drug to improve survival rates in hospitalised coronavirus patients, which truly is a breakthrough."The short timeframe between our first MFT participant being recruited to the RECOVERY trial in March, to our first COVID-19 patient receiving dexamethasone as a standard NHS treatment in June, is an incredible turnaround."This could not have happened without patients consenting to take part in research – which is now directly benefitting all patients.

The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News